Similar articles

• Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation.

  Russell JA, Selby PJ, Ruether BA, Mbidde EK, Ashley S, Zulian G, Berry J, Houwen B, Jones AR, Poon MC, et al. Russell JA, et al. Bone Marrow Transplant. 1989 Jul;4(4):425-9. Bone Marrow Transplant. 1989. PMID: 2673463
• Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.

  Klumpp TR, Mangan KF, Glenn LD, Malaspina DR, Cropper T, Mullaney M, Macdonald JS. Klumpp TR, et al. Bone Marrow Transplant. 1993 Oct;12(4):337-45. Bone Marrow Transplant. 1993. PMID: 7506091 Clinical Trial.
• [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].

  Avigdor A, Hardan I, Shpilberg O, Raanani P, Grotto I, Ben-Bassat I. Avigdor A, et al. Harefuah. 2000 Sep;139(5-6):174-9, 248, 247. Harefuah. 2000. PMID: 11062945 Hebrew.
• Intensive therapy and autotransplantation in Hodgkin's disease.

  Reece DE, Phillips GL. Reece DE, et al. Stem Cells. 1994 Sep;12(5):477-93. doi: 10.1002/stem.5530120504. Stem Cells. 1994. PMID: 7804123 Review.
• Autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.

  Bolwell BJ. Bolwell BJ. Semin Oncol. 1994 Aug;21(4 Suppl 7):86-95. Semin Oncol. 1994. PMID: 7916488 Review.